Company intelligence / Profile preview

Holo Surgical

Chicago, Illinois, United States

Ownership: Private
Development stage: Other

Overview

Holo Surgical developed an augmented reality and artificial intelligence–based digital surgery/navigation platform for spine and other neurosurgical/orthopedic procedures; following acquisition by Surgalign in 2020, the technology (branded HOLO AI and HOLO Portal) received FDA 510(k) clearance in 2022 for use as an AI-driven AR surgical guidance system in lumbar spine surgery and has been used clinically and commercially by Surgalign.[2][5][6][7]

Therapeutic areas: RheumatologyNeurology
Modalities: DeviceNon-pharmacological therapy
Industry: Surgical Medical Devices

Partnerships

Integrated into Surgalign’s spine implants and biomaterials portfolio as the enabling technology platform[2][3]

Beyond the preview

Go deeper on Holo Surgical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Holo Surgical.

Explore the full profile